|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | The Parkinson's Institute |
|---|---|
| Collaborator: |
National Institute of Neurological Disorders and Stroke (NINDS) |
| Information provided by: | The Parkinson's Institute |
| ClinicalTrials.gov Identifier: | NCT00282802 |
Purpose
The purpose of this study is to examine the role of genetic and environmental factors in the cause of Parkinson's disease.
| Condition |
|---|
|
Parkinson's Disease |
| Study Type: | Observational |
| Study Design: | Cohort, Prospective |
| Official Title: | Twins and the Risk of PD: A Clinical and Imaging Study |
| Estimated Enrollment: | 250 |
| Study Start Date: | April 2001 |
| Estimated Study Completion Date: | July 2010 |
| Groups/Cohorts |
|---|
|
1
National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort
|
Parkinson's disease (PD) is a growing health problem in the elderly, and genetic factors may provide substantial clues toward eventual treatment and/or prevention of the disorder. The National Academy of Sciences/National Resource Council (NAS/NRC) World War II (WWII) Veteran Twins Cohort Registry is one of the few population-based groups of elderly twins. Previous studies in this group indicated that genetic factors were involved only in early-onset PD, however there was no follow-up to these studies.
The purpose of the "Twins and the Risk of PD" study is to follow-up previous studies and confirm the initial findings. In this study, investigators will use the NAS/NRC WWII Veteran Twin Cohort Registry to compare the concordance rates for PD in monozygotic and dizygotic twins—at least one of whom has PD.
The overall goal of this research is determine the contributions of genetic and environmental factors in the cause of PD.
The study will involve traditional clinical research methods, such as a clinical examination, as well as innovative imaging techniques, such as single photon emission computed tomography (SPECT). SPECT—a nuclear imaging test involving blood flow to tissue—is used to evaluate certain brain functions.
Findings from this study may help to set research priorities in PD, and to develop tools for early detection of the disorder.
Eligibility| Ages Eligible for Study: | 77 Years to 88 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Participants will be recruited from a closed cohort—the National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort
Inclusion:
Contacts and Locations| United States, California | |
| The Parkinson's Institute, 675 Almanor Avene | |
| Sunnyvale, California, United States, 94085 | |
| Principal Investigator: | Caroline M. Tanner, MD | The Parkinson's Institute |
More Information
| Responsible Party: | The Parkinson's Institute ( Caroline M. Tanner, MD, PhD, Director of Clinical Research ) |
| Study ID Numbers: | R01NS40467, R01 NS 40467-01 |
| Study First Received: | January 26, 2006 |
| Last Updated: | July 1, 2009 |
| ClinicalTrials.gov Identifier: | NCT00282802 History of Changes |
| Health Authority: | United States: Federal Government |
|
Parkinson's Disease twins SPECT |
National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort Registry NAS/NRC World War II Veteran Twins |
|
Movement Disorders Parkinson Disease Nervous System Diseases Basal Ganglia Diseases |
Central Nervous System Diseases Parkinsonian Disorders Neurodegenerative Diseases Brain Diseases |